Financial Performance - For the first quarter of 2025, the company's unaudited consolidated revenue was HKD 2.879 billion, representing a 20% increase compared to HKD 2.399 billion in the same period last year[4]. - The profit attributable to equity holders of the company for the first quarter of 2025 was HKD 34.77 million, a significant increase of 260% from HKD 9.65 million in the previous year[4]. - The total assets as of March 31, 2025, were HKD 5.035 billion, reflecting a 2% increase from HKD 4.938 billion as of December 31, 2024[4]. Segment Performance - The food biotechnology segment generated revenue of HKD 2.355 billion, a 21% increase year-on-year, despite a 7% decline in segment profit to HKD 44.59 million[7]. - The tinplate business produced 76,000 tons of products, a 10% increase year-on-year, with sales of 75,000 tons, representing a 19% increase[8]. - The revenue from the tinplate business was HKD 520 million, a 15% increase compared to the previous year, with segment profit rising 314% to HKD 19.76 million[8]. Challenges and Considerations - The company expects to continue facing challenges due to price fluctuations in pork and demand variability in the tinplate business[12]. - The company emphasizes that quarterly performance may not be indicative of annual results due to market conditions and seasonal factors[12]. Asset Valuation - The company has not recorded any valuation gains or losses on investment properties, maintaining stable property values[10]. - The unaudited financial data for the first quarter of 2025 has been reviewed by the company's audit committee[11].

Financial Performance - The company's consolidated revenue for 2024 reached HKD 11.98 billion, a 15% increase from HKD 10.39 billion in 2023[6]. - Consolidated profit attributable to shareholders was HKD 140.75 million, up 114% from HKD 65.92 million in 2023[7]. - Basic earnings per share increased to HKD 0.1551, a 114% rise compared to HKD 0.0726 in 2023[6]. - Revenue from the food biological segment reached HKD 9.929 billion, a 22% increase year-on-year, with segment profit rising 133% to HKD 234 million[14]. - The group's revenue from the tinplate business was HKD 2.032 billion, a decrease of 10% compared to 2023, with segment profit dropping 55% to HKD 38.51 million[16]. - The property leasing business reported an occupancy rate of 84%, down 3 percentage points from 2023, with revenue decreasing by 10% to HKD 18.03 million[18]. - Net profit for the year increased to HKD 171,022 thousand, a significant rise of 84.3% compared to HKD 92,777 thousand in 2023[158]. - Total comprehensive income for the year was HKD 118,048 thousand, up from HKD 47,097 thousand in 2023, marking a growth of 150.5%[159]. Dividends and Shareholder Returns - The board proposed a final dividend of HKD 0.025 per share, representing a 25% increase from the previous year's HKD 0.020[7]. - The company reported a mid-term dividend of HKD 0.01 per share for 2024, consistent with 2023, and proposed a final dividend of HKD 0.025 per share, up from HKD 0.02 in 2023[43]. - The company aims to maintain a stable and sustainable dividend policy, with dividends proposed semi-annually, subject to the board's assessment of financial performance and future prospects[45]. - The company declared dividends of HKD 9,076,000 for the year, consistent with the previous year's dividend declaration[165]. Assets and Liabilities - Total assets as of December 31, 2024, were HKD 4.94 billion, a 3% increase from HKD 4.79 billion in 2023[6]. - Total assets as of December 31, 2024, amounted to HKD 4.938 billion, while total liabilities increased to HKD 2.081 billion[20]. - Non-current assets decreased to HKD 2,125,575 thousand in 2024 from HKD 2,219,337 thousand in 2023, a decline of 4.2%[161]. - Current assets increased to HKD 2,812,739 thousand in 2024, up from HKD 2,569,664 thousand in 2023, representing a growth of 9.5%[161]. - Total liabilities decreased to HKD 2,856,836 thousand in 2024 from HKD 2,795,645 thousand in 2023, a reduction of 2.1%[162]. - The company’s equity attributable to shareholders increased to HKD 2,592,751 thousand in 2024 from HKD 2,570,014 thousand in 2023, reflecting a growth of 0.9%[162]. Operational Developments - The company plans to invest in an integrated supply chain platform for livestock, including slaughtering, processing, cold chain distribution, and fresh marketing[8]. - The company aims to expand its retail network in Hong Kong and diversify its fruit and vegetable product offerings[8]. - The joint venture in live pig farming turned profitable in 2024, benefiting from improved market conditions and reduced costs[9]. - The company is focused on enhancing its tinplate product quality and expanding its customer base both domestically and internationally[9]. - The group achieved a slaughter volume of over 3 million pigs, securing a leading market share in Guangdong Province[14]. - The group aims to enhance operational efficiency through digital transformation and supply chain optimization in the food biological segment[11]. Investments and Capital Expenditure - Capital expenditure for 2024 was HKD 54.37 million, significantly lower than HKD 261 million in 2023[23]. - The group plans to invest approximately HKD 302 million in capital expenditures for 2025[23]. - The group entered a partnership to establish a slaughterhouse in Foshan with a registered capital of RMB 90 million, with the group holding a 65% stake[24]. Risk Management and Compliance - The group has strengthened its foreign exchange market research and monitoring to mitigate foreign exchange risk, particularly from USD to RMB fluctuations[28]. - The company has implemented internal controls and monitoring systems to manage accounts receivable risks associated with customer creditworthiness[50]. - The company is actively seeking to diversify suppliers for its food biological business to reduce reliance on major suppliers and mitigate risks from potential policy changes[54]. - The company has established a safety production system to mitigate risks associated with machinery operations in its slaughtering and food processing businesses[51]. - The company is committed to enhancing environmental protection measures to mitigate negative impacts from its operations on the environment[53]. Corporate Governance - The board of directors includes both executive and non-executive members, with specific terms for re-election outlined[70]. - The board consists of seven members, including three independent non-executive directors, ensuring a balanced structure for effective oversight[116]. - The company has adhered to the corporate governance code, with the exception of the separation of roles between the chairman and the CEO[103]. - The independent non-executive directors have confirmed their independence as per the listing rules[108]. - The company encourages directors to participate in professional development courses related to corporate governance and compliance, ensuring they remain informed about legal and regulatory updates[113]. Audit and Financial Reporting - The audit committee has reviewed the annual performance for the year ending December 31, 2024[99]. - KPMG has been proposed for reappointment as the independent auditor at the upcoming annual general meeting[100]. - The audit opinion confirmed that the consolidated financial statements fairly present the financial position of the group as of December 31, 2024, in accordance with Hong Kong Financial Reporting Standards[142]. - The auditor's fees for the year ending December 31, 2024, totaled HKD 4,037,000, with HKD 2,800,000 for audit services and HKD 1,237,000 for non-audit services[126]. - The audit committee held four meetings during the year, reviewing the group's 2023 full-year performance and 2024 interim and quarterly results[127]. Environmental and Social Responsibility - The company has committed to environmental sustainability, adhering to international and local regulations, and aims to reduce greenhouse gas emissions[65]. - The company made donations totaling HKD 99,000 during the year, slightly down from HKD 100,000 in 2023[68]. - The company is committed to providing quality products through responsible environmental management and appropriate technology[102].

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責 ， 對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明 ， 並 明 確 表 示 ， 概 不 對 因 本 公 告 全 部 或任何部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任 。 ( 於香港註冊成立的有限公司 ) (股份代號: 01203) 截至2024年12月31日止年度 之全年業績公告 | 截 至 12 月 31 | 日 止 年 度 之 財 務 摘 要 | | | | | --- | --- | --- | --- | --- | | | | 2024 年 | 2023 年 | | | | | 千港元 | 千港元 | 變動 | | 收入 | | 11,978,788 | 10,385,807 | 15% | | 經營溢利 | | 236,146 | 278,222 | -15% | | 股東應佔溢利 | | 140,754 | 65,924 | 114% | | 每股盈利 – 基本 | ...

Financial Performance - For the nine months ended September 30, 2024, the company's unaudited consolidated revenue was HKD 8,584.97 million, an increase of 10.3% compared to HKD 7,786.51 million for the same period last year[3]. - The company's unaudited consolidated operating profit for the same period was HKD 189.77 million, a decrease of 11.2% from HKD 213.76 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders was HKD 115.82 million, representing an 18.0% increase from HKD 98.12 million as of December 31, 2023[3]. Business Segments - The food biological business generated revenue of HKD 7,068.00 million, a 16.4% increase year-on-year, with a segment profit of HKD 156.70 million, up 2.3%[6]. - The live pig slaughter volume exceeded 2.29 million heads, with a market share in Guangdong province ranking among the top[6]. - The tinplate business recorded a revenue of HKD 1,504.00 million, a decrease of 11.6%, with a segment profit of HKD 32.83 million, down 53.7%[7]. Asset and Equity - Total assets as of September 30, 2024, were HKD 4,832.80 million, a 0.9% increase from HKD 4,789.00 million[3]. - Shareholders' equity increased by 2.2% to HKD 2,627.54 million from HKD 2,570.01 million[3]. Market Conditions - The company expects continued volatility in pig prices and fluctuations in customer demand and raw material prices affecting the food biological and tinplate businesses[9]. - The value of the investment properties held by the group decreased, resulting in a valuation loss of HKD 6.75 million for the period[8].

粤海廣南 (集團) 有限公司 GDH GUANGNAN (HOLDINGS) LIMITED (Incorporated in Hong Kong with limited liability) (於香港註冊成立的有限公司) (Stock code 股份代號 : 01203) 海食品 AR & BRILLIANT FOOD 2024 INTERIM REPORT 中期報告 目錄 公司資料 2 財務摘要 3 管理層討論及分析 4 審閱報告 9 未經審核中期財務報告 綜合損益表 10 綜合全面收益表 11 綜合財務狀況表 12 綜合權益變動表 14 簡明綜合現金流量表 16 未經審核中期財務報告附註 17 董事的證券權益及淡倉 36 主要股東權益 37 企業管治及其他資料 38 粵海廣南（集團）有限公司 / 2024年中期報告 1 公司資料 （於2024年8月30日） | --- | --- | --- | |--------------------------------|------------------------------|----------------------------| | | | | | ...

Financial Performance - The group's unaudited consolidated revenue for the first half of 2024 was HKD 5.417 billion, an increase of 8.6% compared to HKD 4.989 billion in the same period last year[3]. - The unaudited consolidated operating profit was HKD 130.53 million, a decrease of 6.3% from HKD 139.25 million year-on-year[3]. - The unaudited consolidated profit attributable to shareholders was HKD 57.73 million, down 2.4% from HKD 59.13 million in the previous year[3]. - Gross profit for the same period was HKD 240,971,000, down 16.7% from HKD 289,624,000 in 2023[19]. - The operating profit decreased to HKD 130,533,000, a decline of 6.2% from HKD 139,252,000 in the previous year[19]. - The net profit attributable to the company's shareholders was HKD 57,727,000, a decrease of 2.4% compared to HKD 59,132,000 in 2023[19]. - Segment profit, including share of losses from joint ventures, was 97,038 thousand for the first half of 2024, down from 116,662 thousand in 2023, indicating a decline of about 16.9%[27]. Revenue Breakdown - The revenue from the food biological segment was HKD 4.429 billion, accounting for 81.8% of the group's total revenue, with a year-on-year increase of 15.6%[5]. - Sales of food biological products amounted to HKD 4,357,394,000, up 16.1% from HKD 3,753,369,000 in the previous year[25]. - The tinplate business generated revenue of HKD 979 million, a decrease of 14.7% compared to the previous year, with a segment profit decline of 71.0% to HKD 14.98 million[6]. - The revenue from tinplate products decreased to HKD 979,256,000, down 14.8% from HKD 1,147,796,000 in the prior year[25]. - The property leasing segment reported an occupancy rate of 82.6%, down 8.0% year-on-year, with revenue of HKD 8.65 million, a decrease of 13.5%[7]. - The rental income from property leasing was HKD 8,649,000, down from HKD 9,997,000 in the previous year[25]. Assets and Liabilities - As of June 30, 2024, the group's total assets were HKD 4.703 billion, while total liabilities were HKD 1.913 billion, reflecting a decrease in both compared to the end of 2023[9]. - The group's cash and cash equivalents amounted to HKD 736 million, a decrease of 28.9% from the end of 2023, with 80.7% in RMB[10]. - Total assets as of June 30, 2024, were 4,702,840 thousand, slightly decreased from 4,789,001 thousand as of December 31, 2023, reflecting a reduction of approximately 1.8%[28]. - Total liabilities decreased to 1,913,144 thousand as of June 30, 2024, from 1,993,356 thousand at the end of 2023, a decline of about 4.0%[28]. - The company's total assets less current liabilities stood at HKD 3,370,148,000, a decrease from HKD 3,424,192,000 at the end of 2023[21]. - The net asset value was HKD 2,789,696,000, a slight decrease from HKD 2,795,645,000 at the end of 2023[21]. Cash Flow and Expenditures - The capital expenditure for the first half of 2024 was HKD 23.42 million, with an estimated total capital expenditure for the year projected at HKD 51.90 million[11]. - The cost of acquiring and relocating property, plant, and equipment for the six months ended June 30, 2024, was HKD 23,420,000, a significant decrease from HKD 259,432,000 in the same period of 2023[38]. - The net cash and cash equivalents as of June 30, 2024, were HKD 736,175,000, a decrease of 29.0% from HKD 1,035,928,000 at the end of 2023[21]. - The available bank financing as of June 30, 2024, was HKD 3,303,849,000, slightly down from HKD 3,308,374,000 as of December 31, 2023[44]. Employee and Operational Metrics - The group employed 1,462 full-time employees as of June 30, 2024, a decrease of 3.8% from 1,520 employees at the end of 2023[16]. - The company is focusing on innovation and quality in its food biotechnology business, aiming for sustainable development and market expansion in the Guangdong-Hong Kong-Macao Greater Bay Area[17]. - The group is enhancing its risk management and optimizing core business strategies to ensure stable growth amid global economic uncertainties[17]. Dividends and Shareholder Information - The company maintained a mid-term dividend of HKD 9,076,000, unchanged from the previous year[19]. - The interim dividend declared for the period was 9,076 thousand, consistent with the same amount declared in the previous year[35]. - The board declared an interim dividend of HKD 0.01 per share for 2024, consistent with the interim dividend of HKD 0.01 per share in 2023[47]. Compliance and Governance - The mid-term performance announcement is published on the Hong Kong Stock Exchange website and the company's website[51]. - The board of directors includes three executive directors and three independent non-executive directors[51]. - The announcement date is August 30, 2024, indicating a timely update for shareholders[51]. - The company is committed to ensuring the accuracy of the information provided in the report[51]. - The chairman of the board is Chen Ben Guang, highlighting leadership continuity[51]. - The board composition suggests a balanced governance structure with both executive and independent members[51].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 (於香港註冊成立的有限公司) (股份代號: 01203) 截至2024年3月31日止三個月之 未經審核季度業績公告 此公告為粵海廣南（集團）有限公司（「本公司」）自願性披露，以務求進一步提 升企業管治的水準，並加強其透明度。 | --- | --- | --- | --- | |--------------|---------------------------------------------------------|------------------------------------|--------| | | | | | | 財務摘要 | | | | | | 截至 3 月 | 31 日止三個月 | | | | 2024 年 | 2023 年 | | | | ( 未經審核 ) ( | 未經審核 ) | | | | | 千港元 千港元 | 變動 | | 收入 | 2,398,673 | 2,32 ...

董事會有責任決定適用於本公司情況的合適企業管治常規，並確保有程序以達到本公司的企業管治目標。 3. 檢討及監察本公司在遵守法律及監管規定方面的政策及常規； 2. 檢討本公司透過審計部及審核委員會實施的內部監控和風險管理系統是否有效。 26 粵海廣南（集團）有限公司 2023年年報 薪酬委員會須每年至少召開兩次會議。於截至2023年12月31日止年度，薪酬委員會舉行四次會議審議薪酬委員會經修訂 的職權範圍、執行董事之薪酬調整及本公司執行董事及高級管理層之年度獎金。 提名委員會由董事會主席陳本光先生及三位獨立非執行董事（Gerard Joseph McMahon先生、李嘉強先生及黃友嘉博士） 組成。陳本光先生獲委任為提名委員會主席。 企業管治報告（續） | --- | --- | |------------|---------------| | 已提供服務 | 費用 \n千港元 | | | | | 審計服務 | 2,750 | | 非審計服務 | 1,643 | | | | | | 4,393 | 審核委員會須每年至少召開四次會議。於截至2023年12月31日止年度，審核委員會共舉行四次會議，其中包括審閱本集 團 ...

Financial Performance - The company's consolidated revenue for the year ended December 31, 2023, was HKD 10.39 billion, an increase of 25.0% from HKD 8.31 billion in 2022[13]. - Consolidated operating profit was HKD 278.22 million, a slight increase of 0.4% compared to HKD 277.03 million in 2022[23]. - Shareholders' profit attributable to the company was HKD 65.92 million, a decrease of 51.4% from HKD 135.67 million in 2022[23]. - Basic earnings per share were HKD 0.073, down 51.0% from HKD 0.149 in 2022[23]. - Net profit for 2023 was HKD 92,777, a decrease of 39.3% from HKD 153,036 in 2022[42]. - The profit for the year was HKD 92,777, a decrease of 39.3% from HKD 153,036 in 2022[89]. - The total comprehensive income for the year amounted to HKD 47,097, compared to a loss of HKD 94,906 in the previous year[89]. - The company reported a total equity of HKD 2,795,645,000, slightly up from HKD 2,783,913,000 in the previous year[100]. Dividends - The company declared an interim dividend of HKD 0.01 per share, consistent with 2022, and proposed a final dividend of HKD 0.02 per share, also unchanged from the previous year[23]. - The board proposed a final dividend of HKD 0.02 per share for the fiscal year 2023, subject to shareholder approval at the annual general meeting[25]. - The proposed final dividend per share increased to 2.0 cents in 2023 from 1.5 cents in 2022, representing a growth of 33.3%[120]. Revenue Segments - The food and biological business segment reported revenue of HKD 8.12 billion, a year-on-year increase of 48.2%, with segment profit rising 33.9% to HKD 204 million[20]. - Revenue from Mainland China was HKD 9,064,873 in 2023, representing a growth of 33.5% from HKD 6,794,760 in 2022[88]. - The group’s revenue from Hong Kong was HKD 809,087 in 2023, up from HKD 528,200 in 2022, marking a growth of 53.2%[88]. - Sales of food biological products amounted to HKD 7,933,711,000, up 50% from HKD 5,296,634,000 in the previous year[100]. - The tinplate segment generated revenue of HKD 2,250,537,000, a decrease of 20% from HKD 2,816,329,000 in 2022[100]. Assets and Liabilities - Total assets as of December 31, 2023, were HKD 4.789 billion, while total liabilities decreased to HKD 1.993 billion, resulting in a net current asset value increase from HKD 962 million to HKD 1.205 billion[34]. - The company’s net current assets increased to HKD 1,204,855,000 from HKD 962,005,000, reflecting a growth of 25.3%[100]. - Total assets minus current liabilities rose to HKD 3,424,192,000, compared to HKD 3,162,750,000 in 2022, indicating an increase of 8.3%[100]. - The group’s total non-current assets in 2023 were HKD 2,133,433, slightly up from HKD 2,115,337 in 2022[88]. Cash Flow and Financing - The company reported a net cash position of HKD 122 million as of December 31, 2023, a decrease of 47.7% from the previous year[35]. - Cash and cash equivalents as of December 31, 2023, were HKD 1,036 million, a decrease of 14.5% from the previous year[60]. - The company’s total cash and cash equivalents were 1,035,928 thousand HKD in 2023, down from 1,211,631 thousand HKD in 2022, a decrease of 14.5%[125]. - The utilized bank financing amount was 1,164,667,000 TWD in 2023, compared to 1,228,182,000 TWD in 2022[163]. - The amount drawn from bank financing was 733,608,000 TWD in 2023, down from 913,486,000 TWD in 2022[163]. Market Conditions and Outlook - The outlook for 2024 indicates potential opportunities and challenges due to a complex international environment and geopolitical tensions, but the company anticipates further recovery in the Chinese economy[17]. - The company faced challenges in the pig farming sector due to low prices and disease outbreaks, leading to increased losses from joint ventures in this area[20]. Strategic Initiatives - The company acquired a 51% stake in Guangdong Yuhai Food Co., Ltd. to enhance its fresh food distribution and retail operations in mainland China[15]. - The company purchased a retail property in Chai Wan to expand its retail business in Hong Kong[15]. - The group plans to invest approximately HKD 37.14 million in capital expenditures for 2024[61]. - The group has strengthened its research and tracking of the foreign exchange market to mitigate risks associated with the fluctuating RMB to USD exchange rate[64]. Employee and Operational Metrics - The company’s workforce increased by 84 employees to a total of 1,520, with 245 employees in Hong Kong and 1,275 in mainland China[41]. - The group’s slaughter volume exceeded 3.09 million heads in 2023, representing a 118.0% increase year-on-year[53].

中期報告 | 公司資料 | 2 | | --- | --- | | 財務摘要 | 3 | | 管理層討論及分析 | 4 | | 審閱報告 | 9 | | 未經審核中期財務報告 | | | 綜合損益表 | 10 | | 綜合全面收益表 | 11 | | 綜合財務狀況表 | 12 | | 綜合權益變動表 | 14 | | 簡明綜合現金流量表 | 16 | | 未經審核中期財務報告附註 | 17 | | 董事的證券權益及淡倉 | 36 | | 主要股東權益 | 37 | | 企業管治及其他資料 | 38 | 粵海廣南（集團）有限公司 / 2023年中期報告 1 公司資料 （於2023年8月31日） 董事會 目錄 執行董事 陳本光 （主席） 楊哲 （總經理） 周宏基 （財務總監） 非執行董事 汪龍海 獨立非執行董事 Gerard Joseph MCMAHON 李嘉強 黃友嘉 金紫荊星章，太平紳士 審核委員會 Gerard Joseph MCMAHON （主席） 李嘉強 黃友嘉 薪酬委員會 李嘉強 （主席） Gerard Joseph MCMAHON 黃友嘉 提名委員會 陳本光 （主席） Gerard Joseph M ...